Compound heterozygous RSPH4A variants associated with suspected primary ciliary dyskinesia in a Chinese family: a case report and literature review.

Authors

Jiali Huang, Fei Tong, Kaiyue Xiao, Xinyu Zhai, Xuyang Zheng

Published in

AME case reports. Volume 10. Pages 209. Epub Aug 19, 2026.

Abstract

Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder caused by defects in ciliary structure and function, leading to impaired mucociliary clearance and chronic respiratory tract infections. The radial spoke head protein 4 homolog A (RSPH4A) gene is one of over 50 genes responsible for causing PCD. The diagnosis of PCD is challenging because symptoms are nonspecific and overlap with common respiratory diseases, such as asthma and recurrent bronchitis, while definitive diagnosis requires specialized and not widely available techniques, such as transmission electron microscopy (TEM) and genetic testing, with test results being not always positive.
The female proband, of 11-year-old, presented chronic cough, recurrent pneumonia, bronchiectasis. Her nasal nitric oxide (nNO) level was 5 ppb, which is markedly below the age-specific reference threshold of 113 ppb for an 11-year-old child. Genetic testing revealed two novel compound heterozygous variants in the RSPH4A gene: a nonsense variant c.658A>T (p.Lys220Ter) and a synonymous variant c.1764G>T (p.Gly588=), both of which were confirmed by Sanger sequencing. Family segregation analysis demonstrated that the proband inherited the two variants from her asymptomatic father and mother, respectively, confirming compound heterozygosity. Although cough symptoms improved following treatment with antibiotics, bronchoscopy secretions aspiration, and inhaled corticosteroids, the follow-up at 3 months revealed persistent moderate obstructive ventilatory dysfunction with no significant improvement.
This case expands the mutational spectrum of RSPH4A-associated PCD and highlights that synonymous variants should not be routinely excluded from pathogenicity assessment in patients with a compatible PCD phenotype.

PMID:
42871315
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.